I’ve been in this stock since 2020 and I’ve done a ton of research on their intranasal ketamine. Patent pending in the states, international patents in place. This is a dual enantiomer ketamine, low dose, non-invasive method of administration. Their stage 2 trial has wrapped up with readout expected mid-September of this year. Read: 3 years guaranteed exclusivity prior to patent approval.
There is hardly any volume in this stock. Almost a hundred institutions own shares and there are several more drugs in the pipeline including a patented version of trelahous for ALS. Am I missing something here? How is this so under the radar?
[link] [comments] https://www.reddit.com/r/stocks/comments/14ysb9w/seelos_therapeutics_seel_volume_so_low_why/
Accedi per aggiungere un commento
Altri post in questo gruppo
Please use this thread to discuss your portfolio, learn of other stock tickers, and help out users by giving constructive criticism.
Why quarterly? Public comp
When you sell a stock to buy another stock, do you prefer to set the estimated amount of the capital gains taxes aside in a money market or do you think it better to
Saving for retirement is crucial, but relying solely on a 401(k) might not be enough due to high inflation. Consider investing in growth stocks, especially in the tec
I’m think this is not a good investment as there is no chatter at all on the 52 week low. They are involved in a class action lawsuits by investors and credit card co
Sorry if this is the wrong sub. Let’s say I had $1 million in VOO but I wanted to sell half of it to buy SCHD. It would suck to pay taxes on $500k. So how would you g
Hey guys, I did a deep dive into Crocs. In this analysis, I will do a brief breakdown of the company and go over some quantitative data, qualitative data and estimate
